by lythamcorp | Nov 5, 2024 | Healthcare, NeurAxis News
CARMEL, Ind., Nov. 05, 2024 — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and...
by lythamcorp | Nov 4, 2024 | Healthcare, NeurAxis News
Clearance expands indication for use from 11-18 year olds to 8-21 year olds; and from 3 devices, not to exceed 4 weeks, to 1 device per week for 4 weeksCARMEL, Ind., Nov. 04, 2024 — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE...
by lythamcorp | Nov 4, 2024 | Healthcare, Iradimed News
WINTER SPRINGS, Fla., Nov. 04, 2024 — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance...
by lythamcorp | Nov 4, 2024 | Energy, Greenfire News, Greenfire Resources
Calgary, Alberta–(November 4, 2024) – Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) (“Greenfire” or the “Company”), a Calgary-based energy company focused on the production and development of thermal energy resources from the...
by lythamcorp | Nov 2, 2024 | Cadrenal Therapeutics, Cadrenal Therapeutics News, Healthcare
PONTE VEDRA, Fla., Nov. 1, 2024 — Cadrenal Therapeutics, Inc., (“Cadrenal” or the “Company”) (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) for...